|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 30, 2018 ) The pain management devices market is estimated to represent a global market of USD 8.1 billion by 2025 with growth rate of 10.9%. Pain is related with a wide range of injury or disease. Some disease conditions may have pain and associated symptoms arising from a discrete cause, like post-operative pain, malignancy, or as neuropathic pains or headaches. Growing awareness among patients regarding pain management devices coupled with favourable government initiatives in order to develop the pain management market, lead to augment the market growth.For example, drug pumps and neurostimulators have been covered under the Medicare, wherein around 80% of the total cost will be covered by the government. These will support the uptake of such devices hence drives the market growth. However, high cost will hamper the market growth.
The market is divided into products, and application. In terms of products, the market is segmented as Electrical Stimulators, Radiofrequency Ablation, Analgesic Infusion Pump and Neurostimulation Market.Neurostimulation segment is considered to be the largest market, accounted for more than USD 1,380 million in 2017. Growing number of Neurostimulation problems worldwide supported the market growth. Electrical stimulator is divided into Transcutaneous Electrical Nerve Stimulation (TENS) and others. Analgesic pumps is segmented into Intrathecal Infusion Pumps, and External Infusion Pumps. Whereas, neurostimulators categorized as Spinal Cord Stimulators, Deep Brain Stimulators and Sacral Neurostimulators.
Request a Free Sample Copy@ http://www.reportsweb.com/inquiry&RW00011327808/sample
Geographically, North America captured 50.89% share of the global market in 2017. For example, according to the American Academy of Pain Medicine, millions of population suffer from chronic or acute pain every year which require immediate medical attention. According to the recent Institute of Medicine Report,(Blueprint for Transforming Prevention, Care, Education, and Research)this pain is a significant public health related problem and costs country US$560- US$635 billion annually, an amount equal US$2,000.00 for everyone living in the U.S. Further, increasing incidence of cancer and other disorders is considered to be the strong driver for the market growth.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY PRODUCTS
Electrical Stimulators
Transcutaneous Electrical Nerve Stimulation (TENS)
Others
Radiofrequency Ablation
Analgesic Infusion Pump
Intrathecal Infusion Pumps
External Infusion Pumps
Neurostimulation
Spinal Cord Stimulators
Deep Brain Stimulators
Sacral Neurostimulators
MARKET, BY APPLICATION
Oncology
Neuropathic
Musculoskeletal
others
MARKET, BY REGION
North America
Europe
Asia Pacific
Rest of the World
MARKET, BY COUNTRY
Further Breakdown of The North America Market
U.S.
Canada
Further Breakdown of The Europe Market
Germany
France
Rest of Europe
Further Breakdown of The APAC Market
India
China
Rest of APAC
Further Breakdown of The Rest of the World Market
Middle East and Africa
Latin America
Inquire before Buying@ http://www.reportsweb.com/inquiry&RW00011327808/buying
Competitive Landscape:
B Braun Melsungen AG
DJO Global LLC
Smiths Medical
Pfizer, Inc.
Codman
Baxter
Boston Scientific
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
